Literature DB >> 26564145

Tripterysium glycosides preconditioning attenuates renal ischemia/reperfusion injury in a rat model.

Zhi-Shun Wang1, Tao Qiu2, Xiu-Heng Liu3, Jiang-Qiao Zhou2, Zhong-Bao Chen2, Lei Wang4, Long Zhang4, Ye Shen4, Lu Zhang4.   

Abstract

BACKGROUND: Ischemia-reperfusion (I/R) injury to the kidney occurs commonly in organ transplantation from donation after cardiac death, involving many pathologic processes. In this study, we used rat model to assess whether tripterysium glycosides (TG) preconditioning could exert protective effects in renal I/R injury.
MATERIALS AND METHODS: All male SD rats were randomly divided into four groups (6 each): sham group, TG group, I/R group and TG + I/R group. Groups TG and TG + I/R were pretreated with TG at 0.1 mg/kg for 14 days; groups sham and I/R were administered with the same dosage of normal saline. Groups TG + I/R and I/R underwent 45 min of renal ischemia of left kidney after right nephrectomy, and then, they were subjected to 72-h reperfusion. Groups sham and TG were only received right nephrectomy. The indicators of apoptosis, fibrosis and inflammation were analyzed to evaluate the effect of tripterysium glycosides preconditioning on renal I/R injury.
RESULTS: Pretreatment with TG significantly inhibited the levels of serum creatine and blood urea nitrogen and improved histologic lesions induced by I/R injury. Moreover, for the apoptosis signal pathway, pretreatment with TG markedly decreased the expression of caspase-3 and Bax and increased the level of Bcl-2. HMGB1, which was regarded as one of inflammation marker molecule, it was inhibited in the TG + I/R group. For the fibrosis signal pathway, the pretreatment with TG before I/R could down-regulate the expression level of typical molecules of fibrosis (TGF-β1, Smad3, p-Smad3).
CONCLUSIONS: Pretreatment with tripterysium glycosides exhibited protective effect on kidney ischemia/reperfusion injury, which might be related to the alleviation of inflammation, fibrosis and the reduction in apoptosis.

Entities:  

Keywords:  Apoptosis; Fibrosis; Ischemia reperfusion; Kidney transplantation; Tripterysium glycosides

Mesh:

Substances:

Year:  2015        PMID: 26564145     DOI: 10.1007/s11255-015-1160-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

Review 1.  Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents.

Authors:  Kwong-Fai Wong; Yi Yuan; John M Luk
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-03       Impact factor: 2.557

Review 2.  Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms.

Authors:  Zhao-Li Zhou; Ya-Xi Yang; Jian Ding; Yuan-Chao Li; Ze-Hong Miao
Journal:  Nat Prod Rep       Date:  2012-01-23       Impact factor: 13.423

3.  [Effect of Tripterygium glycosides on expression of hypoxia inducible factor-1α and endothelin-1 in kidney of diabetic rats].

Authors:  Wei-Dong Chen; Bao-Chao Chang; Yan Zhang; Ping Yang; Lei Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2015-04

4.  Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.

Authors:  Heng Zhou; Wei Guo; Cong Long; Huan Wang; Jingchao Wang; Xiaoping Sun
Journal:  Biochem Biophys Res Commun       Date:  2014-12-13       Impact factor: 3.575

5.  Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation.

Authors:  Bernd Krüger; Stefanie Krick; Navdeep Dhillon; Susan M Lerner; Scott Ames; Jonathan S Bromberg; Marvin Lin; Liron Walsh; John Vella; Michael Fischereder; Bernhard K Krämer; Robert B Colvin; Peter S Heeger; Barbara T Murphy; Bernd Schröppel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

7.  Effects of ischemia-reperfusion injury in kidney transplantation: risk factors and early and long-term outcomes in a single center.

Authors:  P Ditonno; S V Impedovo; S Palazzo; C Bettocchi; L Gesualdo; G Grandaliano; F P Selvaggi; M Battaglia
Journal:  Transplant Proc       Date:  2013-09       Impact factor: 1.066

8.  Effect of Cordyceps sinensis and Tripterygium wilfordii polyglycosidium on podocytes in rats with diabetic nephropathy.

Authors:  Li Hao; Meng-Shu Pan; Yun Zheng; Rui-Feng Wang
Journal:  Exp Ther Med       Date:  2014-04-07       Impact factor: 2.447

Review 9.  The complement system in ischemia-reperfusion injuries.

Authors:  William B Gorsuch; Elvina Chrysanthou; Wilhelm J Schwaeble; Gregory L Stahl
Journal:  Immunobiology       Date:  2012-08-07       Impact factor: 3.144

10.  Neuroprotective effects of DAHP and Triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activation.

Authors:  Weiyun Li; Yang Yang; Zhiying Hu; Shucai Ling; Marong Fang
Journal:  Front Neuroanat       Date:  2015-04-22       Impact factor: 3.856

View more
  3 in total

1.  The effects of oxidative stress following ischemia-reperfusion injury.

Authors:  Ali Kagan Coskun; Yalcin Basaran
Journal:  Int Urol Nephrol       Date:  2016-03-31       Impact factor: 2.370

2.  Danhong injection represses diabetic retinopathy and nephropathy advancement in diabetic mice by upregulating microRNA-30d-5p and targeting JAK1.

Authors:  Wei Deng; Dan Huang; HongWu Xie; LiMin Wang; Qun Shen; RongRong Zeng; YuanLian Huang; JianHua Li; Bo Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  TRPM7 in CHBP-induced renoprotection upon ischemia reperfusion-related injury.

Authors:  Aifen Liu; Jing Wu; Cheng Yang; Yuanyuan Wu; Yufang Zhang; Fengbo Zhao; Hui Wang; Li Yuan; Lirui Song; Tongyu Zhu; Yaping Fan; Bin Yang
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.